BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Dina H. Kandil, Kumarasen Cooper. Glypican-3Advances in Anatomic Pathology 2009; 16(2): 125 doi: 10.1097/PAP.0b013e3181992455
2
Xiao-Bo Man, Liang Tang, Bao-Hua Zhang, Shen-Jing Li, Xiu-Hua Qiu, Meng-Chao Wu, Hong-Yang Wang. Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancersLiver International 2005; 25(5): 962 doi: 10.1111/j.1478-3231.2005.01100.x
3
Jorge Filmus, Mariana Capurro. Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular CarcinomaMolecular Diagnosis 2004; 8(4): 207 doi: 10.1007/BF03260065
4
Xiao-Yan Cao, Jie Liu, Zhao-Rui Lian, Marcy Clayton, Jia-Lu Hu, Ming-Hua Zhu, Dai-Ming Fan, Mark Feitelson. Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in miceWorld Journal of Gastroenterology 2001; 7(4): 575-578 doi: 10.3748/wjg.v7.i4.575
5
JuanPing Yu, Qiang Ma, Bin Zhang, RuiJuan Ma, XiGuang Xu, MingSong Li, WeiWen Xu, Ming Li. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosisScience China Life Sciences 2013; 56(3): 234 doi: 10.1007/s11427-013-4451-y
6
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognosticationChinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
7
Dina Kandil, Gladwyn Leiman, Mark Allegretta, Winifred Trotman, Liron Pantanowitz, Robert Goulart, Mark Evans. Glypican-3 immunocytochemistry in liver fine-needle aspiratesCancer 2007; 111(5): 316 doi: 10.1002/cncr.22954
8
Gang Zhang, Mian Long, Zhe-Zhi Wu, Wei-Qun Yu. Mechanical properties of hepatocellular carcinoma cellsWorld Journal of Gastroenterology 2002; 8(2): 243-246 doi: 10.3748/wjg.v8.i2.243
9
Juan-Ping Yu, Xi-Guang Xu, Rui-Juan Ma, Shi-Ni Qin, Cong-Rong Wang, Xiao-Bo Wang, Ming Li, Ming-Song Li, Qiang Ma, Wei-Wen Xu. Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular CarcinomaJournal of Clinical Laboratory Analysis 2015; 29(2): 85 doi: 10.1002/jcla.21733
10
Ahmad Saad, Benjamin Liet, Gilles Joucla, Xavier Santarelli, Justine Charpentier, Stéphane Claverol, Christophe F. Grosset, Véronique Trézéguet. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma CellsBiochemistry 2018; 57(7): 1201 doi: 10.1021/acs.biochem.7b01208
11
Xiao-Yan Cao, Jie Liu, Zhao-Rui Lian, Marcy Clayton, Jia-Lu Hu, Ming-Hua Zhu, Dai-Ming Fan, Mark Feitelson. Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liverWorld Journal of Gastroenterology 2001; 7(4): 579-582 doi: 10.3748/wjg.v7.i4.579
12
Dina Kandil, Gladwyn Leiman, Mark Allegretta, Mark Evans. Glypican-3 protein expression in primary and metastatic melanomaCancer Cytopathology 2009; 117(4): 271 doi: 10.1002/cncy.20032
13
Samah S. Elbasateeny, Taiseer R. Ibrahim. The utility of immunohistochemical expression of glypican-3 (GPC3) and enhancer of zeste homologue-2 (EZH2) protein in the diagnosis of liver nodulesEgyptian Journal of Pathology 2016; 36(2): 267 doi: 10.1097/01.XEJ.0000508565.38041.da
14
Jing Fu, Hongyang Wang. Precision diagnosis and treatment of liver cancer in ChinaCancer Letters 2018; 412: 283 doi: 10.1016/j.canlet.2017.10.008
15
Hongyang Wang, Wen Wen. Primary Liver Cancer2012; : 79 doi: 10.1007/978-3-642-28702-2_4
16
Jorge Filmus, Mariana Capurro. Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular CarcinomaMolecular Diagnosis 2004; 8(4): 207 doi: 10.1007/BF03260065